Risk factors and screening strategy for group B streptococcal colonization in pregnant women: Results of a prospective study;Facteurs de risque et stratégie de dépistage de la colonisation par le streptocoque du groupe B chez la femme enceinte: Résultats d'une étude prospective

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 32, Issue 2, 2003, Pages 132-138

  Jaureguy F ^a,d   Carton, M ^b   Teboul, J ^a   Butel, M J ^c   Panel, P ^c   Ghnassia, J C ^a   Doucet Populaire, F ^c  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

^b Hospital National de Saint Maurice   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d AVICENNE HOSPITAL   (France)

Author keywords

Colonization; Groupe B streptococcus; Pregnancy; Risk factors; Screening

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CEPHALOSPORIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN DERIVATIVE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PREGNANCY; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SCREENING; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VAGINA SMEAR; FRANCE; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; MICROBIOLOGY; RECTUM; VAGINA;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFTRIAXONE; ERYTHROMYCIN; FEMALE; FRANCE; HUMANS; MASS SCREENING; PENICILLINS; PREGNANCY; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECTUM; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA;

EID: 0038322368     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Prévention anténatale du risque infectieux bactérien néonatal précoce. Recommandation pour la pratique clinique. Agence Nationale d'Accréditation et d'Évaluation en Santé. 2001.
2. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics 1999; 104: 203-9.
3. Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group. Pediatr Infect Dis J 1994; 13: 623-9.
4. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention [published erratum appears in MMWR Morb Mortal Wkly Rep 1996; 45: 679]. MMWR Morb Mortal Wkly Rep 1996; 45: 1-24.
5. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15-20.
6. ACOG committee opinion. Prevention of early-onset group B streptococcal disease in newborns. Number 173-June 1996. Committee on Obstetric Practice. American College of Obstetrics and Gynecologists. Int J Gynaecol Obstet 1996; 54: 197-205.
7. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics 1997; 99: 489-96.
8. Poulain P, Betremieux P, Donnio PY, Proudhon JF, Karege G, Giraud JR. Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries. Eur J Obstet Gynecol Reprod Biol 1997; 72: 137-40.
9. Volumenie JL, Fernandez H, Vial M, Lebrun L, Frydman R. Neonatal group B streptococcal infection. Results of 33 months of universal maternal screening and antibioprophylaxis. Eur J Obstet Gynecol Reprod Biol 2001; 94: 79-85.
10. Madani TA, Harding GK, Helewa M, Alfa MJ. Screening pregnant women for group B streptococcal colonization. Infection 1998; 26: 288-91.
11. Philipson EH, Palermino DA, Robinson A. Enhanced antenatal detection of group B streptococcus colonization. Obstet Gynecol 1995; 85: 437-9.
12. Platt MW, McLaughlin JC, Gilson GJ, Wellhoner MF, Nims LJ. Increased recovery of group B Streptococcus by the inclusion of rectal culturing and enrichment. Diagn Microbiol Infect Dis 1995; 21: 65-8.
13. Quinlan JD, Hill DA, Maxwell BD, Boone S, Hoover F, Lense JJ. The necessity of both anorectal and vaginal cultures for group B streptococcus screening during pregnancy. J Fam Pract 2000; 49: 447-8.
14. Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 1983; 148: 802-9.
15. Dillon HC, Jr., Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis 1982; 145: 794-9.
16. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996; 88: 811-5.
17. Fenton LJ, Harper MH. Evaluation of colistin and nalidixic acid in Todd-Hewitt broth for selective isolation of group B streptocci. J Clin Microbiol 1979; 9: 167-9.
18. Baker CJ, Clark DJ, Barrett FF. Selective broth medium for isolation of group B streptococci. Appl Microbiol 1973; 26: 884-5.
19. De Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998; 91: 112-4.
20. Fitoussi F, Loukil C, Gros I, Clermont O, Mariani P, Bonacorsi S, Le Thomas I, Deforche D, Bingen E. Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother 2001; 45: 1889-91.
21. Betriu C, Gomez M, Sanchez A, Cruceyra A, Romero J, Picazo JJ. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother 1994; 38: 2183-6.
22. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol 1998; 92: 258-61.
23. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998; 42: 1517-9.
24. Terry RR, Kelly FW, Gauzer C, Jeitler M. Risk factors for maternal colonization with group B beta-hemolytic streptococci. J Am Osteopath Assoc 1999; 99: 571-3.
25. Ramos E, Gaudier FL, Hearing LR, Del Valle GO, Jenkins S, Briones D. Group B streptococcus colonization in pregnant diabetic women. Obstet Gynecol 1997; 89: 257-60.